PHOENIX BIOTECH ACQUISITION's ticker is and the CUSIP is 71902K113. A total of 44 filers reported holding PHOENIX BIOTECH ACQUISITION in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $21,480 | +17.2% | 300,000 | 0.0% | 0.00% | – |
| Q2 2023 | $18,330 | +52.6% | 300,000 | 0.0% | 0.00% | – |
| Q1 2023 | $12,015 | -7.1% | 300,000 | 0.0% | 0.00% | – |
| Q4 2022 | $12,930 | -46.1% | 300,000 | 0.0% | 0.00% | – |
| Q3 2022 | $24,000 | -20.0% | 300,000 | 0.0% | 0.00% | – |
| Q2 2022 | $30,000 | -53.8% | 300,000 | 0.0% | 0.00% | -100.0% |
| Q1 2022 | $65,000 | -48.4% | 300,000 | 0.0% | 0.00% | 0.0% |
| Q4 2021 | $126,000 | – | 300,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MANGROVE PARTNERS IM, LLC | 163,538 | $1,746,586 | 0.12% |
| Q Global Advisors, LLC | 170,785 | $7 | 0.01% |
| Atalaya Capital Management LP | 225,000 | $9,000 | 0.00% |
| MMCAP International Inc. SPC | 375,000 | $15,000 | 0.00% |
| Segantii Capital Management Ltd | 5,000 | $53,400 | 0.00% |
| DIFESA CAPITAL MANAGEMENT, LP | 62,500 | $2,506 | 0.00% |
| PERISCOPE CAPITAL INC. | 957,098 | $38,301 | 0.00% |
| Sage Rock Capital Management LP | 91,999 | $3,689 | 0.00% |
| Castle Creek Arbitrage, LLC | 200,000 | $8,000 | 0.00% |
| Context Capital Management, LLC | 200,000 | $8 | 0.00% |